AWARD
A -- DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS
- Notice Date
- 9/8/2014
- Notice Type
- Award Notice
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions, 6700 B Rockledge Room 3214 MSC7612, Bethesda, Maryland, 20892-7612
- ZIP Code
- 20892-7612
- Solicitation Number
- BAA-NIAID-DMID-NIHAI2013174
- Archive Date
- 10/17/2013
- Point of Contact
- Michael Welsh, Phone: (301) 451-2569, Michael Finn, Phone: 301-496-3699
- E-Mail Address
-
welshmi@mail.nih.gov, finnm@mail.nih.gov
(welshmi@mail.nih.gov, finnm@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Award Number
- HHSN272201400038C
- Award Date
- 9/4/2014
- Awardee
- Emergent BioSolutions
- Award Amount
- Total Base + Options $29,184,146
- Description
- The objective of this contract is to support the advanced development of candidate products, which consist of a vaccine component in combination with a dry formulation technology (also referred to as solid vaccine formulations), that increase duration of stability and minimize cold chain or preservative requirements. These products will likely be used to minimize the need for preservatives for in post-event settings following the intentional release of NIAID Category A, B and C Priority Pathogens or in response to naturally occurring outbreaks of infectious diseases caused by NIAID Category A, B and C Priority Pathogens.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIAID/BAA-NIAID-DMID-NIHAI2013174/listing.html)
- Place of Performance
- Address: TBD, United States
- Record
- SN03501576-W 20140910/140909023309-44e4f5d6590394d714c70f9128ebc36d (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |